Clearmind Medicine Inc. financial data

Symbol
CMND on Nasdaq
Industry
Pharmaceutical Preparations
Location
101 1220 West 6 Th Avenue, Vancouver, British Columbia, Canada (Federal Level)
State of incorporation
Canada (Federal Level)
Fiscal year end
October 31
Latest financial report
6-K - Q4 2023 - Mar 19, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 607K shares -54%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 227K USD -61.3%
General And Administrative Expense 1.16M USD -7.14%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 10.1M USD
Liabilities 5.06M USD